tiprankstipranks
Trending News
More News >
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market

Virax Biolabs Group Ltd. Class A (VRAX) Balance Sheet

Compare
123 Followers

Virax Biolabs Group Ltd. Class A Balance Sheet

Virax Biolabs Group Ltd. Class A's total assets for Q2 2026 were $5.72M, a decrease of -11.08% from the previous quarter. VRAX total liabilities were $641.52K for the fiscal quarter, a -33.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 6.43M$ 5.48M$ 9.81M$ 48.71K$ 94.12K
Total Liabilities
$ 964.75K$ 345.19K$ 908.40K$ 1.25M$ 871.43K
Total Equity Gross Minority
$ 5.46M$ 5.14M$ 8.90M$ -1.20M$ -777.32K
Other Metrics
Currency in USD

Virax Biolabs Group Ltd. Class A Debt to Assets